Acute cardiac care & resuscitation

Beneficial Effects of Ketone Ester in Patients With Cardiogenic Shock: A Randomized, Controlled, Double-Blind Trial

JACC Heart FailPublished Randomised crossover trial

Authors' conclusion

Treatment with KE improved cardiac output, biventricular function, tissue oxygenation, and glycemic control in patients with CS

Study context

Population
Patients with cardiogenic shockcrossover
Participants
12 patients
Comparison
Ketone ester vs placebo
Primary endpoint
Hemodynamic effects (cardiac output)
Follow-up
3 hours after each intervention
Methodological detailsdouble-blind, placebo-controlled
  • Double-blind
  • Placebo-controlled

Primary result

As reported in the abstract

Cardiac output (AUC of relative change)

P = 0.044

Further findings

Circulating 3-hydroxybutyrate

P < 0.001

OutcomeIncrease (W) (95% CI)P value
Cardiac power output, mixed venous saturation, forearm perfusionCardiac power output0.07 (0.01–0.14)P = 0.037
OutcomeIncrease (percentage points) (95% CI)P value
Cardiac power output, mixed venous saturation, forearm perfusionMixed venous saturation3 (1–5)P = 0.010
Cardiac power output, mixed venous saturation, forearm perfusionForearm perfusion3 (0–6)P = 0.026

Ventricular filling pressures, HR, mean arterial and pulmonary arterial pressures

Right ventricular filling pressure reduced
P = 0.048
Left ventricular filling pressure reduced
P = 0.017
HR and mean arterial and pulmonary arterial pressures remained similar

LVEF, glucose, insulin

LVEF improved
4 percentage points (95% CI: 2-6 percentage points; P = 0.005)
Glucose decreased
2.6 mmol/L (95% CI: −5.2 to 0.0; P = 0.047)
Insulin levels remained unaltered

Original publication

Beneficial Effects of Ketone Ester in Patients With Cardiogenic Shock: A Randomized, Controlled, Double-Blind Trial. JACC Heart Fail. Published 12 July 2023. doi:10.1016/j.jchf.2023.05.029

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.